Ditchcarbon
  • Contact
  1. Organizations
  2. TerSera Therapeutics LLC
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 24 days ago

TerSera Therapeutics LLC Sustainability Profile

Company website

TerSera Therapeutics LLC, a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2015, the company has rapidly established itself as a leader in developing innovative therapies for patients with unmet medical needs, particularly in the areas of oncology and rare diseases. With a focus on precision medicine, TerSera's core products include advanced therapeutics that leverage cutting-edge research and technology, setting them apart in a competitive market. The company has achieved significant milestones, including strategic partnerships and successful product launches, which have solidified its position as a trusted name in the healthcare sector. TerSera Therapeutics continues to drive advancements in treatment options, demonstrating a commitment to improving patient outcomes and enhancing the quality of life for those they serve.

DitchCarbon Score

How does TerSera Therapeutics LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

TerSera Therapeutics LLC's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.

34%

Let us know if this data was useful to you

TerSera Therapeutics LLC's reported carbon emissions

TerSera Therapeutics LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that TerSera may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives at this time. As the company operates within a sector increasingly focused on sustainability, it may benefit from developing clear climate strategies and targets to align with broader industry trends and expectations.

How Carbon Intensive is TerSera Therapeutics LLC's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. TerSera Therapeutics LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is TerSera Therapeutics LLC's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for TerSera Therapeutics LLC is in US, which has a low grid carbon intensity relative to other regions.

TerSera Therapeutics LLC's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

TerSera Therapeutics LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare TerSera Therapeutics LLC's Emissions with Industry Peers

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Celgene Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 20 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Eisai

JP
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy